南新制药（688189.SH）12月16日在投资者互动平台表示，尊敬的投资者，您好！公司暂无疫苗类产 品。感谢您的关注！ （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：很多中小学实施免费打流感疫苗，请问公司有中标的 疫苗吗？ ...

Core Viewpoint - The company, Luyan Pharmaceutical, confirmed its involvement in the storage, cold chain transportation, and distribution services for vaccine products, including influenza vaccines, as part of its main business operations [1]. Group 1 - The company primarily engages in the distribution of pharmaceuticals, traditional Chinese medicine pieces, and medical devices [1]. - The main source of revenue for the company is from pharmaceutical wholesale sales [1]. - The company has capabilities that include the storage and distribution of vaccine products [1].

Core Insights - The South Korean health industry has achieved a record high in exports in the first half of the year, driven by significant growth in cosmetics and pharmaceuticals [1] Group 1: Export Performance - The total export value of the South Korean health industry reached $13.79 billion, marking a year-on-year increase of 13.2% [1] - Cosmetics exports amounted to $5.51 billion, with a year-on-year growth of 14.9%, while pharmaceuticals reached $5.38 billion, growing by 20.5% [1] - Both cosmetics and pharmaceuticals achieved their highest export values for the first half of the year [1] Group 2: Sector Contributions - Basic skincare products accounted for 74.6% of cosmetics exports, performing well in markets such as the United States, Hong Kong, and Poland [1] - The growth in pharmaceuticals was primarily driven by biopharmaceuticals and vaccine products [1] Group 3: Medical Devices - The medical device sector experienced a slight decline, with exports decreasing from $2.92 billion in the first half of last year to $2.91 billion this year, a drop of 0.6% [1]